Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET

Clinical Nuclear Medicine

Volumn 34, Issue 5, 2009, Pages 302-304

  Abiko, Tomohiro ^a   Koizumi, Satoko ^a   Takanami, Iwao ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

11C acetate PET; FDG PET; Lung cancer; Subclavicular angiosarcoma

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE; ACETIC ACID DERIVATIVE; CARBON; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ANGIOSARCOMA; ARTICLE; BIOPSY; BRONCHOSCOPY; CANCER CYTODIAGNOSIS; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG LAVAGE; LUNG SURGERY; PRIMARY TUMOR; SUBCLAVICULAR ANGIOSARCOMA; THORACOSCOPY; ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; LUNG TUMOR; MULTIPLE CANCER; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; UTERINE CERVIX TUMOR;

ACETATES; ADENOCARCINOMA; AGED; CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HEMANGIOSARCOMA; HUMANS; LUNG NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 67849116966     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31819e5242     Document Type: Article

References (12)

1. Zhang Y, Li G, Zhuang H. Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma. Clin Nucl Med. 2008;33:109-110.
2. Bakheet SM, Powe J, Ezzat A, et al. Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan. Clin Nucl Med. 1998;23:616.
3. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752-757.
4. Zhuang H, Hickeson M, Chacko TK, et al. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med. 2002;27:628-632.
5. Nguyen BD. Incidental PET/CT detection of thyroid and breast cancer during recurrence of colorectal carcinoma. Clin Nucl Med. 2007;32:59-63.
6. Cook GJ, Houston S, Barrington SF, et al. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med. 1998;39:99-103.
7. Messa C, Goodman WG, Hoh CK, et al. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab. 1993;77:949-955.
8. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-1976.
9. Schiepers C, Broos P, Miserez M, et al. Measurement of skeletal flow with positron emission tomography and 18F-fluoride in femoral head osteonecrosis. Arch Orthop Trauma Surg. 1998;118:131-135.
10. Berding G, Buret al. Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F]fluoride ion and dynamic positron emission tomography. Eur J Nucl Med. 1995;22:1133-1140.
11. Piert M, Winter E, Becker GA, et al. Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [18F]fluoride ion positron emission tomography. Eur J Nucl Med. 1999;26:615-624.
12. 11C-Acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Ann Thorac Surg. 2005;80:2020-2025.